FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline Nicotine polacrilex lozenge Recall

Nicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count cartons,…

GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline · Aiken, SC

Risk level
Class III
Reported by FDA
Apr 30, 2014
Recall ID
D-1241-2014
Check your lot numberHow we source this data

Summary

GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline recalled Nicotine polacrilex lozenge starting Feb 20, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1241-2014 on Apr 30, 2014. Reason: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent. Status: Terminated.

Why it was recalled

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Product description

Nicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labeled a. Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108. Made in Switzerland. 72 Count NDC: 0135-0510-01,108 Count NDC: 0135-0514-03, b. Nicotine Lozenge Kroger, Lozenge Kroger, Distributed by: The Kroger Company, Cincinnati, Ohio 45202, 72 Count NDC: 30142-861-01. c. Nicotine Walgreens, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015. 108 Count NDC: 0363-0208-07.

Lot numbers, UPCs & expiration codes

Labeled A) 72 Count Vial, Lot # 13404 (exp 4/14),13499 (exp 5/14), 13549 (exp 6/14), 14004 (exp 1/15), 14079 (exp 2/15), 14178 (exp 5/15), 14297 (exp 7/15) & 14425 (exp 9/15); 108 Ct Vial: Lot # 13449 (exp 5/14), 13657 (exp 8/14), 13723 (exp 8/14), 13781 (exp 11/14), 13867 (exp 11/14), 13897 (exp 12/14), 13960 (exp 1/15), 13981 (exp 12/14), 14016 (exp 2/15), 14254 (exp 7/15), 14305 (exp 7/15), 14341 (exp 7/15), 14370 (exp 8/15) & 14465 (exp 11/15). Labeled B) 72 Count Vial, Lot #13417 (exp 5/14), 13570 (exp 6/14), 13974 (exp 1/15), 14089 (exp 2/15), 14225 (exp 5/15), 14269 (exp 7/15), 14311 (exp 7/15) & 14396 (exp 8/15).Labeled C) 108 Ct Vial: Lot #:13656 (exp 8/14), 13753 (exp 9/14).

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1241-2014
Classification
Class III
Status
Terminated
Recall initiated
Feb 20, 2014
FDA report date
Apr 30, 2014
Quantity
488,628 72 Ct Vial, 255,594 108 Ct Vial
Recall type
Voluntary: Firm initiated
Recalling firm
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Original FDA data

Every field from FDA enforcement report D-1241-2014, exactly as published.

Show all FDA fields
City
Aiken
State
SC
Status
Terminated
Country
United States
Event ID
67800
Address
65 Windham Blvd
Code information
Labeled A) 72 Count Vial, Lot # 13404 (exp 4/14),13499 (exp 5/14), 13549 (exp 6/14), 14004 (exp 1/15), 14079 (exp 2/15), 14178 (exp 5/15), 14297 (exp 7/15) & 14425 (exp 9/15); 108 Ct Vial: Lot # 13449 (exp 5/14), 13657 (exp 8/14), 13723 (exp 8/14), 13781 (exp 11/14), 13867 (exp 11/14), 13897 (exp 12/14), 13960 (exp 1/15), 13981 (exp 12/14), 14016 (exp 2/15), 14254 (exp 7/15), 14305 (exp 7/15), 14341 (exp 7/15), 14370 (exp 8/15) & 14465 (exp 11/15). Labeled B) 72 Count Vial, Lot #13417 (exp 5/14), 13570 (exp 6/14), 13974 (exp 1/15), 14089 (exp 2/15), 14225 (exp 5/15), 14269 (exp 7/15), 14311 (exp 7/15) & 14396 (exp 8/15).Labeled C) 108 Ct Vial: Lot #:13656 (exp 8/14), 13753 (exp 9/14).
Postal code
29805-9384
Report date
Apr 30, 2014
Product type
Drugs
Recall number
D-1241-2014
Classification
Class III
Recalling firm
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Product quantity
488,628 72 Ct Vial, 255,594 108 Ct Vial
Termination date
Jan 20, 2017
Reason for recall
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. Labeled a. Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108. Made in Switzerland. 72 Count NDC: 0135-0510-01,108 Count NDC: 0135-0514-03, b. Nicotine Lozenge Kroger, Lozenge Kroger, Distributed by: The Kroger Company, Cincinnati, Ohio 45202, 72 Count NDC: 30142-861-01. c. Nicotine Walgreens, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015. 108 Count NDC: 0363-0208-07.
Distribution pattern
U.S. Nationwide
Recall initiation date
Feb 20, 2014
Initial firm notification
Letter
Center classification date
Apr 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1241-2014, published Apr 30, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls